{"id":396576,"date":"2020-12-09T10:43:20","date_gmt":"2020-12-09T15:43:20","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=396576"},"modified":"2020-12-09T10:43:20","modified_gmt":"2020-12-09T15:43:20","slug":"tmx-group-imv-c-suite-at-the-open","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tmx-group-imv-c-suite-at-the-open\/","title":{"rendered":"TMX Group, IMV, C-Suite at The Open"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">Canada NewsWire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"xn-location\">TORONTO<\/span>, <span class=\"xn-chron\">Dec. 9, 2020<\/span> \/CNW\/\u00a0&#8211; Fred Ors, CEO, IMV Inc. (TSX: IMV), shares his\u00a0company&#8217;s\u00a0story in an <b><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3007773-1&amp;h=1536246349&amp;u=https%3A%2F%2Fwww.youtube.com%2Fwatch%3Fv%3DOaOXlg4YtA4%26feature%3Dyoutu.be&amp;a=interview\" rel=\"nofollow noopener noreferrer\">interview<\/a><\/b>\u00a0with TMX Group.<\/p>\n<p>The C-Suite at The Open video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange.\u00a0 Videos provide insight into how company executives think in the current business environment.\u00a0 To see the latest C-Suite at The Open videos visit <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3007773-1&amp;h=2171705180&amp;u=https%3A%2F%2Fwww.tmxmoney.com%2Fen%2Fcsuite.html&amp;a=https%3A%2F%2Fwww.tmxmoney.com%2Fen%2Fcsuite.html\" rel=\"nofollow noopener noreferrer\">https:\/\/www.tmxmoney.com\/en\/csuite.html<\/a>.<\/p>\n<p>\n        <b><br \/>\n          <u>About IMV Inc. (TSX: IMV)<br \/><\/u><br \/>\n        <\/b>\n      <\/p>\n<p>IMV Inc. is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure of antigens to the immune system. For more information visit: <a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3007773-1&amp;h=3788468088&amp;u=https%3A%2F%2Fwww.imv-inc.com%2F&amp;a=https%3A%2F%2Fwww.imv-inc.com%2F\" rel=\"nofollow noopener noreferrer\">https:\/\/www.imv-inc.com\/<\/a>\u00a0<\/p>\n<p>\n        <b><br \/>\n          <u>About TMX Group (TSX: X)<\/u><br \/>\n        <\/b>\n      <\/p>\n<p>TMX Group&#8217;s key subsidiaries operate cash and derivative markets and clearinghouses for multiple asset classes including equities and fixed income. <u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3007773-1&amp;h=2526609765&amp;u=http%3A%2F%2Ftmx.com%2F&amp;a=Toronto+Stock+Exchange\" rel=\"nofollow noopener noreferrer\">Toronto Stock Exchange<\/a><\/u>, <u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3007773-1&amp;h=663000444&amp;u=http%3A%2F%2Ftmx.com%2F&amp;a=TSX+Venture+Exchange\" rel=\"nofollow noopener noreferrer\">TSX Venture Exchange<\/a><\/u>, <u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3007773-1&amp;h=1246601761&amp;u=http%3A%2F%2Ftmx.com%2F&amp;a=TSX+Alpha+Exchange\" rel=\"nofollow noopener noreferrer\">TSX Alpha Exchange<\/a><\/u>, <u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3007773-1&amp;h=934118155&amp;u=http%3A%2F%2Fwww.cds.ca%2F&amp;a=The+Canadian+Depository+for+Securities\" rel=\"nofollow noopener noreferrer\">The Canadian Depository for Securities<\/a><\/u>, <u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3007773-1&amp;h=1273661528&amp;u=http%3A%2F%2Fwww.m-x.ca%2F&amp;a=Montr%C3%A9al+Exchange\" rel=\"nofollow noopener noreferrer\">Montr\u00e9al Exchange<\/a><\/u>, <u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3007773-1&amp;h=1147223556&amp;u=http%3A%2F%2Fwww.cdcc.ca%2F&amp;a=Canadian+Derivatives+Clearing+Corporation\" rel=\"nofollow noopener noreferrer\">Canadian Derivatives Clearing Corporation<\/a><\/u>, <u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3007773-1&amp;h=1421546296&amp;u=https%3A%2F%2Fwww.trayport.com%2Fuk%2Fhome&amp;a=Trayport\" rel=\"nofollow noopener noreferrer\">Trayport<\/a><\/u>\u00a0and other TMX Group companies provide listing markets, trading markets, clearing facilities, depository services, technology solutions, data products and other services to the global financial community. TMX Group is headquartered in <span class=\"xn-location\">Toronto<\/span> and operates offices across <span class=\"xn-location\">North America<\/span> (Montr\u00e9al, <span class=\"xn-location\">Calgary<\/span>, <span class=\"xn-location\">Vancouver<\/span> and <span class=\"xn-location\">New York<\/span>), as well as in key international markets including <span class=\"xn-location\">London<\/span>, <span class=\"xn-location\">Beijing<\/span> and <span class=\"xn-location\">Singapore<\/span>. For more information about TMX Group, visit our website at <u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3007773-1&amp;h=139075784&amp;u=http%3A%2F%2Fwww.tmx.com%2F&amp;a=www.tmx.com\" rel=\"nofollow noopener noreferrer\">www.tmx.com<\/a><\/u>. Follow TMX Group on Twitter: <u><a target=\"_blank\" href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=3007773-1&amp;h=851187188&amp;u=http%3A%2F%2Fwww.twitter.com%2Ftmxgroup&amp;a=%40TMXGroup\" rel=\"nofollow noopener noreferrer\">@TMXGroup<\/a><\/u>.<\/p>\n<p>SOURCE  TMX Group Limited<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C8870&amp;Transmission_Id=202012091040CANADANWWEB______C8870&amp;DateId=20201209\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Canada NewsWire TORONTO, Dec. 9, 2020 \/CNW\/\u00a0&#8211; Fred Ors, CEO, IMV Inc. (TSX: IMV), shares his\u00a0company&#8217;s\u00a0story in an interview\u00a0with TMX Group. The C-Suite at The Open video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange.\u00a0 Videos provide insight into how company executives think in the current business environment.\u00a0 To see the latest C-Suite at The Open videos visit https:\/\/www.tmxmoney.com\/en\/csuite.html. About IMV Inc. (TSX: IMV) IMV Inc. is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tmx-group-imv-c-suite-at-the-open\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;TMX Group, IMV, C-Suite at The Open&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-396576","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TMX Group, IMV, C-Suite at The Open - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tmx-group-imv-c-suite-at-the-open\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TMX Group, IMV, C-Suite at The Open - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Canada NewsWire TORONTO, Dec. 9, 2020 \/CNW\/\u00a0&#8211; Fred Ors, CEO, IMV Inc. (TSX: IMV), shares his\u00a0company&#8217;s\u00a0story in an interview\u00a0with TMX Group. The C-Suite at The Open video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange.\u00a0 Videos provide insight into how company executives think in the current business environment.\u00a0 To see the latest C-Suite at The Open videos visit https:\/\/www.tmxmoney.com\/en\/csuite.html. About IMV Inc. (TSX: IMV) IMV Inc. is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure &hellip; Continue reading &quot;TMX Group, IMV, C-Suite at The Open&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tmx-group-imv-c-suite-at-the-open\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-09T15:43:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C8870&amp;Transmission_Id=202012091040CANADANWWEB______C8870&amp;DateId=20201209\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tmx-group-imv-c-suite-at-the-open\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tmx-group-imv-c-suite-at-the-open\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TMX Group, IMV, C-Suite at The Open\",\"datePublished\":\"2020-12-09T15:43:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tmx-group-imv-c-suite-at-the-open\\\/\"},\"wordCount\":276,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tmx-group-imv-c-suite-at-the-open\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/rt.prnewswire.com\\\/rt.gif?NewsItemId=C8870&amp;Transmission_Id=202012091040CANADANWWEB______C8870&amp;DateId=20201209\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tmx-group-imv-c-suite-at-the-open\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tmx-group-imv-c-suite-at-the-open\\\/\",\"name\":\"TMX Group, IMV, C-Suite at The Open - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tmx-group-imv-c-suite-at-the-open\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tmx-group-imv-c-suite-at-the-open\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/rt.prnewswire.com\\\/rt.gif?NewsItemId=C8870&amp;Transmission_Id=202012091040CANADANWWEB______C8870&amp;DateId=20201209\",\"datePublished\":\"2020-12-09T15:43:20+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tmx-group-imv-c-suite-at-the-open\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tmx-group-imv-c-suite-at-the-open\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tmx-group-imv-c-suite-at-the-open\\\/#primaryimage\",\"url\":\"https:\\\/\\\/rt.prnewswire.com\\\/rt.gif?NewsItemId=C8870&amp;Transmission_Id=202012091040CANADANWWEB______C8870&amp;DateId=20201209\",\"contentUrl\":\"https:\\\/\\\/rt.prnewswire.com\\\/rt.gif?NewsItemId=C8870&amp;Transmission_Id=202012091040CANADANWWEB______C8870&amp;DateId=20201209\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tmx-group-imv-c-suite-at-the-open\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TMX Group, IMV, C-Suite at The Open\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TMX Group, IMV, C-Suite at The Open - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tmx-group-imv-c-suite-at-the-open\/","og_locale":"en_US","og_type":"article","og_title":"TMX Group, IMV, C-Suite at The Open - Market Newsdesk","og_description":"Canada NewsWire TORONTO, Dec. 9, 2020 \/CNW\/\u00a0&#8211; Fred Ors, CEO, IMV Inc. (TSX: IMV), shares his\u00a0company&#8217;s\u00a0story in an interview\u00a0with TMX Group. The C-Suite at The Open video interview series highlights the unique perspectives of listed companies on Toronto Stock Exchange and TSX Venture Exchange.\u00a0 Videos provide insight into how company executives think in the current business environment.\u00a0 To see the latest C-Suite at The Open videos visit https:\/\/www.tmxmoney.com\/en\/csuite.html. About IMV Inc. (TSX: IMV) IMV Inc. is a clinical-stage biopharmaceutical company. The company is engaged in making immunotherapies more effective, more broadly applicable, and more widely available to people facing cancer and other serious diseases. Its proprietary drug development platform provides a patented delivery formulation that enables controlled and prolonged exposure &hellip; Continue reading \"TMX Group, IMV, C-Suite at The Open\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tmx-group-imv-c-suite-at-the-open\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-09T15:43:20+00:00","og_image":[{"url":"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C8870&amp;Transmission_Id=202012091040CANADANWWEB______C8870&amp;DateId=20201209","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tmx-group-imv-c-suite-at-the-open\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tmx-group-imv-c-suite-at-the-open\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TMX Group, IMV, C-Suite at The Open","datePublished":"2020-12-09T15:43:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tmx-group-imv-c-suite-at-the-open\/"},"wordCount":276,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tmx-group-imv-c-suite-at-the-open\/#primaryimage"},"thumbnailUrl":"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C8870&amp;Transmission_Id=202012091040CANADANWWEB______C8870&amp;DateId=20201209","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tmx-group-imv-c-suite-at-the-open\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tmx-group-imv-c-suite-at-the-open\/","name":"TMX Group, IMV, C-Suite at The Open - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tmx-group-imv-c-suite-at-the-open\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tmx-group-imv-c-suite-at-the-open\/#primaryimage"},"thumbnailUrl":"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C8870&amp;Transmission_Id=202012091040CANADANWWEB______C8870&amp;DateId=20201209","datePublished":"2020-12-09T15:43:20+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tmx-group-imv-c-suite-at-the-open\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tmx-group-imv-c-suite-at-the-open\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tmx-group-imv-c-suite-at-the-open\/#primaryimage","url":"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C8870&amp;Transmission_Id=202012091040CANADANWWEB______C8870&amp;DateId=20201209","contentUrl":"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=C8870&amp;Transmission_Id=202012091040CANADANWWEB______C8870&amp;DateId=20201209"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tmx-group-imv-c-suite-at-the-open\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TMX Group, IMV, C-Suite at The Open"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/396576","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=396576"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/396576\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=396576"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=396576"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=396576"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}